Vitalea Science and Radiopharma Combine Expertise to Advance Global Pharmaceutical Development

Eckert & Ziegler Vitalea Science (EZVS) is pleased to introduce complementary products and services of Radiopharma, a longstanding business segment within the Eckert & Ziegler family.

Headquartered in Berlin with technical support and business development locations in Mainz, Bonn, Brunswick, Washington DC and Boston, Radiopharma specializes in molecular imaging and nuclear medicine, and supplies radiopharmaceuticals, radiochemicals and related equipment for synthesis and radiochromatography of PET/SPECT tracers for the medical and pharmaceutical industries.

As many pharmaceutical companies expand in-house research facilities to include imaging capabilities, Radiopharma is a strong fit and complement to the bioanalytical accelerator mass spectrometry (AMS) service offerings of EZVS. “The two business segments have great synergy and share some of the same clients. We believe that this partnership will allow Eckert & Ziegler to add value to our existing customer base, as well as penetrate deeper into the pharmaceutical market” says Frank Yeager, President & CEO of Eckert & Ziegler Isotope Products.

Focused on providing continuous client satisfaction in a steadily growing customer network, this partnering of resources is essential for achieving and maintaining the innovation and quality expected from the global pharma industry. Yeager continues, “We look forward to being able to continue expanding our business and helping our customers by providing an array of services with world class customer support.”

To learn more about our combined products and service offerings, visit with the Eckert & Ziegler family of companies at the upcoming Society of Nuclear Medicine and Molecular Imaging Annual meeting in beautiful Vancouver, BC June 8-12. Come see us in booth 420!